Sonia Faria Mendes Braga1, Mirian Carvalho de Souza2, Mariangela Leal Cherchiglia3. 1. Department of Social and Preventive Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais (UFMG). Av. Alfredo Balena, 190-sala: 706, Belo Horizonte, MG, CEP: 30130-100, Brazil. Electronic address: sonia.fm.braga@gmail.com. 2. Department of Epidemiology, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rua Marquês de Pombal, 125-7° andar-Centro, Rio de Janeiro, RJ, CEP: 20230-240, Brazil. Electronic address: miriancs@inca.gov.br. 3. Department of Social and Preventive Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais (UFMG). Av. Alfredo Balena, 190-sala: 706, Belo Horizonte, MG, CEP: 30130-100, Brazil. Electronic address: cherchml@medicina.ufmg.br.
Abstract
BACKGROUND: In the 1980s, an increase in mortality rates for prostate cancer was observed in North America and developed European countries. In the 1990s, however, mortality rates decreased for these countries, an outcome related to early detection of the disease. Conversely, an upward trend in mortality rates was observed in Brazil. This study describe the trends in mortality for prostate cancer in Brazil and geographic regions (North, Northeast, South, Southeast, and Central-West) between 1980 until 2014 and analyze the influence of age, period, and cohort effects on mortality rates. METHODS: This time-series study used data from the Mortality Information System (SIM) and population data from Brazilian Institute for Geography and Statistics (IBGE). The effects on mortality rates were examined using age-period-cohort (APC) models. RESULTS: Crude and standardized mortality rates showed an upward trend for Brazil and its regions more than 2-fold the last 30 years. Age effects showed an increased risk of death in all regions. Period effects showed a higher risk of death in the finals periods for the North and Northeast. Cohort effects showed risk of death was higher for younger than older generations in Brazil and regions, mainly Northeast (RRAdjusted=3.12, 95% CI 1.29-1.41; RRAdjusted=0.28, 95% CI 0.26-0.30, respectively). CONCLUSION: The increase in prostate cancer mortality rates in Brazil and its regions was mainly due to population aging. The differences in mortality rates and APC effects between regions are related to demographic differences and access of health services across the country.
BACKGROUND: In the 1980s, an increase in mortality rates for prostate cancer was observed in North America and developed European countries. In the 1990s, however, mortality rates decreased for these countries, an outcome related to early detection of the disease. Conversely, an upward trend in mortality rates was observed in Brazil. This study describe the trends in mortality for prostate cancer in Brazil and geographic regions (North, Northeast, South, Southeast, and Central-West) between 1980 until 2014 and analyze the influence of age, period, and cohort effects on mortality rates. METHODS: This time-series study used data from the Mortality Information System (SIM) and population data from Brazilian Institute for Geography and Statistics (IBGE). The effects on mortality rates were examined using age-period-cohort (APC) models. RESULTS: Crude and standardized mortality rates showed an upward trend for Brazil and its regions more than 2-fold the last 30 years. Age effects showed an increased risk of death in all regions. Period effects showed a higher risk of death in the finals periods for the North and Northeast. Cohort effects showed risk of death was higher for younger than older generations in Brazil and regions, mainly Northeast (RRAdjusted=3.12, 95% CI 1.29-1.41; RRAdjusted=0.28, 95% CI 0.26-0.30, respectively). CONCLUSION: The increase in prostate cancer mortality rates in Brazil and its regions was mainly due to population aging. The differences in mortality rates and APC effects between regions are related to demographic differences and access of health services across the country.
Authors: M Sanni Ali; Maria Yury Ichihara; Luciane Cruz Lopes; George C G Barbosa; Robespierre Pita; Roberto Perez Carreiro; Djanilson Barbosa Dos Santos; Dandara Ramos; Nivea Bispo; Fabiana Raynal; Vania Canuto; Bethania de Araujo Almeida; Rosemeire L Fiaccone; Marcos E Barreto; Liam Smeeth; Mauricio L Barreto Journal: Front Pharmacol Date: 2019-09-23 Impact factor: 5.810
Authors: Hyun Young Lee; Do Kyoung Kim; Seung Whan Doo; Won Jae Yang; Yun Seob Song; Bora Lee; Jae Heon Kim Journal: Cancer Res Treat Date: 2019-08-01 Impact factor: 4.679
Authors: Carlos Anselmo Lima; Brenda Evelin Barreto da Silva; Evânia Curvelo Hora; Marcela Sampaio Lima; Erika de Abreu Costa Brito; Marceli de Oliveira Santos; Angela Maria da Silva; Marco Antonio Prado Nunes; Hugo Leite de Farias Brito; Marcia Maria Macedo Lima Journal: PLoS One Date: 2021-03-25 Impact factor: 3.240
Authors: Diego Bessa Dantas; Lucio Flávio Garcia Rodrigues; Fabiana de Campos Gomes; João Simão de Melo-Neto Journal: Ecancermedicalscience Date: 2020-05-04